Insider · SEC Form 4 filer
Jack Schuler
Companies
Where they file as an insider
Biodesix (BDSX) 10% owner Latest filing Nov 10, 2026
Aspira Women's Health (AWHL) 10% owner Latest filing Jun 5, 2026
Accelerate Diagnostics (AXDX) Director, 10% owner Latest filing Dec 3, 2024
Yield10 Bioscience (YTEN) 10% owner Latest filing Dec 20, 2023
Track record
Did their buys beat the typical stock?
Open-market buys9
Quarters checked 6 months later1
Beat the typical stock —
Quarters too new to check0
Too soon to tell. 1 quarter has finished so far. We show a record once 3 have.
Biodesix (BDSX) Bought Aug 29–Sep 19, 2025 · $2.61M · 3.65M shares Beat typical Sep 30, 2025 $7.55 → Mar 31, 2026 $14.50 · +92.1% (typical stock −3.4%)
Biodesix (BDSX) Bought May 16–19, 2025 · $1.33M · 4.72M shares Not counted Not counted. We have no fund price for this stock on both Jun 30, 2025 and Dec 31, 2025.
Biodesix (BDSX) Bought Nov 5–21, 2024 · $493K · 400,253 shares Not counted Not counted. We have no fund price for this stock on both Dec 31, 2024 and Jun 30, 2025.
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.